MGNX — MacroGenics Cashflow Statement
0.000.00%
Last trade - 00:00- $181.77m
- $61.86m
- $149.50m
Annual cashflow statement for MacroGenics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -202 | -120 | -9.06 | -67 | -74.6 |
| Depreciation | |||||
| Non-Cash Items | 26.8 | 23.7 | -136 | -10.3 | 14.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 20.3 | -2.79 | 56.8 | 1.39 | -28.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -144 | -87 | -78.2 | -68.4 | -81 |
| Capital Expenditures | -6.2 | -3.62 | -1.76 | -3.71 | -1.91 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -30.4 | 74.3 | -78.3 | 153 | -112 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -36.6 | 70.7 | -80.1 | 149 | -114 |
| Financing Cash Flow Items | — | — | 149 | 0 | 69.7 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 123 | 1.66 | 150 | 0.96 | 69.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -57.7 | -14.6 | -7.93 | 81.9 | -126 |